Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest versus continuous oral contraceptive pills after laparoscopic surgery for endometriosis
IRCT20120201008897N7Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dienogest in endometriosis (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Recurrence and Pain. Started Jun 2019; status: completed.
02
Drugs
dienogest
03
Conditions
endometriosis
Beyond the preview
Go deeper on IRCT20120201008897N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120201008897N7.